Gene · 79813
Papers2,587
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,587
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Maintenance of neuronal fate and transcriptional identity. | Biol Open | 2023 | 37272626 | PubTator, text mining | PubMed |
| Systematic literature review reveals suboptimal use of chemical probes in cell-based biomedical research. | Nat Commun | 2023 | 37270653 | PubTator, text mining | PubMed |
| Structure-Based Design and Characterization of the Highly Potent and Selective Covalent Inhibitors Targeting the Lysine Methyltransferases G9a/GLP. | J Med Chem | 2023 | 37268593 | PubTator, text mining | PubMed |
| Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis mediated by weight loss: findings from the Shanghai Osteoarthritis Cohort. | Ann Rheum Dis | 2023 | 37258065 | PubTator, text mining | PubMed |
| Cell consequences of loss of function of the epigenetic factor EHMT1. | Cell Signal | 2023 | 37257768 | PubTator, text mining | PubMed |
| Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists. | Pharmaceuticals (Basel) | 2023 | 37242457 | PubTator, text mining | PubMed |
| Effective Generation of Functional Pancreatic β Cells from Human-Derived Dental Stem Cells of Apical Papilla and Bone-Marrow-Derived Stem Cells: A Comparative Study. | Pharmaceuticals (Basel) | 2023 | 37242432 | PubTator, text mining | PubMed |
| Intestinal Enteroendocrine Cells: Present and Future Druggable Targets. | Int J Mol Sci | 2023 | 37240181 | PubTator, text mining | PubMed |
| TNFα Effects on Adipocytes Are Influenced by the Presence of Lysine Methyltransferases, G9a (EHMT2) and GLP (EHMT1). | Biology (Basel) | 2023 | 37237488 | PubTator, text mining | PubMed |
| Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease-Current Background, Hopes, and Perspectives. | Metabolites | 2023 | 37233622 | PubTator, text mining | PubMed |
| Understanding and targeting resistance mechanisms in cancer. | MedComm (2020) | 2023 | 37229486 | PubTator, text mining | PubMed |
| H3 histone methylation landscape in male urogenital cancers: from molecular mechanisms to epigenetic biomarkers and therapeutic targets. | Front Cell Dev Biol | 2023 | 37228649 | PubTator, text mining | PubMed |
| Post-translational modifications of histones: Mechanisms, biological functions, and therapeutic targets. | MedComm (2020) | 2023 | 37220590 | PubTator, text mining | PubMed |
| GSK-3484862 targets DNMT1 for degradation in cells. | NAR Cancer | 2023 | 37206360 | PubTator, text mining | PubMed |
| The function of histone methylation and acetylation regulators in GBM pathophysiology. | Front Oncol | 2023 | 37205197 | PubTator, text mining | PubMed |
| Euchromatic Histone Lysine Methyltransferase 2 Inhibition Enhances Carfilzomib Sensitivity and Overcomes Drug Resistance in Multiple Myeloma Cell Lines. | Cancers (Basel) | 2023 | 37190128 | PubTator, text mining | PubMed |
| Role of brahma-related gene 1/brahma-associated factor subunits in neural stem/progenitor cells and related neural developmental disorders. | World J Stem Cells | 2023 | 37181007 | PubTator, text mining | PubMed |
| Epigenetic plasticity safeguards heterochromatin configuration in mammals. | Nucleic Acids Res | 2023 | 37178005 | PubTator, text mining | PubMed |
| Exploring the Genetic Predisposition to Epigenetic Changes in Alzheimer's Disease. | Int J Mol Sci | 2023 | 37175659 | PubTator, text mining | PubMed |
| Development of a reference and proficiency chemical list for human steatosis endpoints in vitro. | Front Endocrinol (Lausanne) | 2023 | 37168981 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79813/papers?page=16